Cynthia “Cindy” Dukes | Senior Therapeutic Strategy Director, Medical and Site Operations
Avacare
Cynthia “Cindy” Dukes, PA, MT, currently serves as Senior Therapeutic Strategy Director for Avacare Clinical Research Network of 40+ multi-therapeutic sites. With over 40 years of diversified clinical experience, Cindy is a distinguished professional and thought leader in the vaccine industry. Her extensive background spans Site, Pharma, Biotech, and CRO domains, covering multiple therapeutic areas such as vaccines, infectious diseases, oncology, rare diseases and more.
Throughout her career, Cindy has consulted with firms developing vaccines for various conditions, including Covid-19, Meningococcal, Influenza, Chlamydia, Herpes, and more. Her contributions span over 40+ INDs, 20 vaccine approvals, 2 oncology products approvals, and an immunoglobulin approval.
Cindy has been recognized as one of the Top 50 Influential People in Vaccine Development by a global Vaccine Nation Survey, as well as a Distinguished Alumni at Baylor College of Medicine and Top Leader by Pharm Times.
Appearances:
Main Congress Day 2 - 23rd April @ 15:10
Achieving vaccine research excellence: Key insights for sponsors, CROs, and PIs
In the dynamic field of vaccine research, selecting and partnering with high-quality clinical research sites is crucial for success. This presentation will provide a comprehensive roadmap tailored to the unique demands of vaccine studies, detailing the necessary steps to establish, maintain, and evaluate a high-quality clinical research sites. We will delve into the critical factors that ensure successful vaccine trials, including PI engagement, facility requirements, staff training, and quality control measures. Through real-life examples and case studies, attendees will gain actionable insights to advance vaccine research and foster strong, collaborative partnerships.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events